Why Participate

Why Participate?

More than 1.1 million Americans are currently living with or in remission from a blood cancer. Every three minutes, someone is diagnosed. Every ten minutes, someone dies from these cancers. They are men, women and children of every race and every age. Participation in LLS's Man & Woman of the Year helps save lives not someday, but today.

The Leukemia & Lymphoma Society has invested more than $1 billion in research to advance breakthrough therapies that are saving lives today. Almost half of the new anti-cancer drugs approved in the U.S. from 2000 through 2013 (31 of 81) were FDA approved for blood cancer patients, and LLS helped advance most of them.

In fiscal year 2013 alone, LLS supported research here in the U.S. and abroad, and also funded advocacy for lifesaving treatments as well as critically needed patient support services. LLS will continue to support research and make a huge impact through their innovative and integrated funding programs until every patient has a safe and effective therapy.

Learn more about LLS.


Max, Survivor

Max was diagnosed with Acute Lymphoblastic Leukemia when he was 3 years old. Treated at U-Mass in Worcester, Max was able to participate in a patient study and picked for the most intense course of treatment.

Today, Max is 8 years old and loves playing basketball and hockey with his brothers. While he has had plenty of ups and downs during treatment, he always manages to keep a smile on his face.


  • HonCode Logo
  • BBB Logo
  • Charity Navigator Logo
  • GuideStar Logo